Viewing Study NCT05863260


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-03-05 @ 8:13 PM
Study NCT ID: NCT05863260
Status: UNKNOWN
Last Update Posted: 2023-05-18
First Post: 2023-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab Combing Chemoradiotherapy in Recurrent Cervical Cancer
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cervical Cancer View
None Immune Checkpoint Inhibitor View
None Chemoradiotherapy View
Keywords: